SCHEDULE 13G: Deep Track Capital Discloses 5.5% Passive Stake in Geron Corp

Deep Track Capital, LP, along with Deep Track Biotechnology Master Fund, Ltd. and David Kroin, has disclosed a passive beneficial ownership of 5.5% in Geron Corp's common stock.

Summary

• Deep Track Capital, LP, Deep Track Biotechnology Master Fund, Ltd., and David Kroin collectively reported beneficial ownership of 35,000,000 shares of Geron Corp's Common Stock.
• This ownership represents 5.50% of Geron Corp's outstanding common stock, calculated based on 636,904,470 shares outstanding as of February 21, 2025.
• The reporting persons share both voting and dispositive power over all 35,000,000 shares.
• The filing indicates that the securities were not acquired and are not held for the purpose of changing or influencing the control of Geron Corp, signifying a passive investment.

Sentiment

Score: 7

Explanation: The disclosure of a significant passive stake by a reputable investment firm is generally viewed as a positive signal, indicating institutional confidence in the company, although the filing itself is purely factual and does not contain performance data.

Positives

• The disclosure of a significant 5.5% stake by a specialized investment firm like Deep Track Capital could be interpreted as a vote of confidence in Geron Corp's future prospects by institutional investors.

Future Outlook

NA

Industry Context

This filing indicates a significant investment by a specialized biotechnology fund in Geron Corp, a company operating within the biotechnology sector. Such investments can signal institutional interest in the company's pipeline or market position.

Stakeholder Impact

• Shareholders: The disclosure of a new significant institutional investor may positively influence investor sentiment and potentially the stock price, signaling confidence in the company.

Key Dates

Keywords

Geron Corp, Deep Track Capital, Beneficial Ownership, SEC Filing, Schedule 13G, Common Stock, Biotechnology, Investment, Passive Stake